Moleculin Biotech, Inc.
MBRX
$0.77
$0.011.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.26M | 10.32M | 8.88M | 6.70M | 7.56M |
| Total Receivables | 4.00K | 9.00K | 7.00K | 6.00K | 5.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.07M | 299.00K | 523.00K | 809.00K | 1.10M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 388.00K | 336.00K | 278.00K | 367.00K | 411.00K |
| Total Current Assets | 8.72M | 10.96M | 9.69M | 7.89M | 9.08M |
|
|
|||||
| Total Current Assets | 8.72M | 10.96M | 9.69M | 7.89M | 9.08M |
| Net Property, Plant & Equipment | 316.00K | 354.00K | 392.00K | 420.00K | 469.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 900.00K | 900.00K | 900.00K | 900.00K | 900.00K |
| Total Assets | 21.09M | 23.36M | 22.13M | 20.35M | 21.59M |
|
|
|||||
| Total Accounts Payable | 4.34M | 4.57M | 3.51M | 2.12M | 3.72M |
| Total Accrued Expenses | 4.83M | 3.25M | 3.21M | 3.43M | 4.06M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 145.00K | 141.00K | 137.00K | 132.00K | 128.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.31M | 7.96M | 6.85M | 5.68M | 7.91M |
|
|
|||||
| Total Current Liabilities | 9.31M | 7.96M | 6.85M | 5.68M | 7.91M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 147.00K | 185.00K | 222.00K | 258.00K | 292.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 40.00K | 33.00K | 44.00K | 41.33M | 20.55M |
| Total Liabilities | 9.50M | 8.18M | 7.12M | 47.27M | 28.76M |
|
|
|||||
| Common Stock & APIC | 238.14M | 234.08M | 221.00M | 194.68M | 160.32M |
| Retained Earnings | -226.48M | -218.85M | -206.00M | -221.56M | -167.44M |
| Treasury Stock & Other | -64.00K | -52.00K | 10.00K | -44.00K | -38.00K |
| Total Common Equity | 11.59M | 15.18M | 15.01M | -26.92M | -7.17M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.59M | 15.18M | 15.01M | -26.92M | -7.17M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.59M | 15.18M | 15.01M | -26.92M | -7.17M |
|
|
|||||